The Simpson-Bowles Part D rebates would undermine competition, result in fewer choices of drugs for the sickest seniors, and wind up costing taxpayers and seniors more over the long run.
FORBES: In The Fight At The Fiscal Cliff, Don't Throw The Valuables Over The Side